Miliary tuberculosis after infliximab therapy in Lebanon
- 1 June 2004
- journal article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 23 (3) , 279-280
- https://doi.org/10.1007/s10067-004-0873-z
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance reportArthritis & Rheumatism, 2003
- Tuberculosis in the cytokine era: What rheumatologists need to knowArthritis & Rheumatism, 2003
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Epidemiology of tuberculosis in Lebanon.1999